Home ›
Organizations ›
BETH ISRAEL LAHEY HEALTH PHARMACY INC
BETH ISRAEL LAHEY HEALTH PHARMACY INC
MA · Healthcare · EIN 822526816
30
Executives Disclosed
$292.5M
Annual Revenue
$119.7M
Total Assets
13.3:1
Internal Pay Ratio
BETH ISRAEL LAHEY HEALTH PHARMACY INC has 30 executives with disclosed compensation. The highest-paid executive, Kevin Tabb, MD (CEO (EX-OFF) (CEO, BILH)), received peak total compensation of $5,410,415. The sector average for Healthcare executives is $506K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Kevin Tabb, MD | CEO (EX-OFF) (CEO, BILH) | $5.4M | $5.4M | 2018–2024 | 72.1x |
| Michael Rowan | TTEE(EXO)(CEO DESIG)EVP HOS&AMB BILH | $4.7M | $4.7M | 2021–2024 | 62.7x |
| Steven P Fischer | DIRECTOR, TREASURER | $1.7M | $1.7M | 2019–2020 | 23.2x |
| Cindy Rios | TREAS (EX-OFF) (EXEC VP & CFO, BILH) | $1.7M | $1.7M | 2024–2024 | 22.5x |
| Steven Fischer | BILH CFO, TRUSTEE, TREASURER (EX-OFFICIO) | $1.4M | $1.4M | 2018–2021 | 18.4x |
| Jamie Katz, ESQ | CLERK (EX-OFF); GENERAL COUNSEL BILH | $1.3M | $1.3M | 2019–2024 | 17.4x |
| Robert Fields, MD | CHAIR&TTEE (CHIEF CLIN OFF, BILH) | $1.3M | $1.3M | 2024–2024 | 17.1x |
| Jess Dejesus | PRES/TTEE (EX-OFF); CHIEF PHARM OFF | $910K | $910K | 2024–2024 | 12.1x |
| Efstathios Antoniades | TRUSTEE | $681K | $681K | 2021–2021 | 9.1x |
| Richard Fernandez | TRUSTEE | $670K | $670K | 2021–2024 | 8.9x |
| Jamie W Katz | DIRECTOR, SECRETARY; SVP BIDMC | $660K | $660K | 2018–2018 | 8.8x |
| Carl Francioli | TTEE (CFO, BIDMC) | $601K | $601K | 2024–2024 | 8x |
| Michael R Cullen | FRMR TTEE; CFO/SVP FINANCE, BIDMC | $586K | $260K | 2021–2024 | 7.8x |
| Nicole Devita | TTEE; COO BILH PERFORMANCE NETWORK | $581K | $581K | 2021–2024 | 7.7x |
| Tina Jones | ASSTTREAS&TEE (CFO PHARM/DIVERS SVCS | $451K | $451K | 2024–2024 | 6x |
| Neil Gilrchrist | VP, PHARMACY OPERATIONS | $408K | $408K | 2024–2024 | 5.4x |
| Siepka Rph Ms Fache Thomas | CHIEF PHARMACY OFFICER, BIDMC AND BIDMC PHARMACY | $407K | $407K | 2021–2021 | 5.4x |
| John Marshall | VICE PRESIDENT, CLINICAL PHARMACY | $404K | $404K | 2024–2024 | 5.4x |
| Zemler Wu Sherman | VP PHARM STRAT & BUS DEV, BILH PHARM | $403K | $403K | 2020–2024 | 5.4x |
| Connie Woodworth | TRUSTEE (EX-OFFICIO) | $388K | $388K | 2021–2021 | 5.2x |
| Sinthusan Sinnadurai | VP PHARMACY BENEFITS MANAGER | $382K | $382K | 2024–2024 | 5.1x |
| Thomas J Siepka | VP CHF PHARM OFF. BIDMC PHARM | $364K | $364K | 2019–2020 | 4.8x |
| Quan Pho | INTERIM CHIEF PHARMACY OFFICER | $350K | $350K | 2021–2021 | 4.7x |
| Hope Violette | AVP, REGULATORY AND COMPLIANCE | $314K | $314K | 2024–2024 | 4.2x |
| Parth Patel | DIRECTOR, PHARMACY DATA ANALYTICS | $295K | $295K | 2024–2024 | 3.9x |
| Desai R Ph Chirag | EXEC. DIRECTOR, PHARMACY, BILH NETWORK | $262K | $262K | 2018–2021 | 3.5x |
| Luca Cattaneo | DIRECTOR SPECIALTY PHARMACY | $247K | $247K | 2024–2024 | 3.3x |
| Tara Lech | DIR, PHARMACY ANTICOAGULATION SVCS | $214K | $214K | 2024–2024 | 2.9x |
| Jay Bornstein | DIRECTOR, PHARMACY SUPPLY CHAIN | $203K | $203K | 2024–2024 | 2.7x |
| Beaumier Mbacpamha Gregory | TTEE (CHIEF FINANCIAL OFFICER, NHC) | $140K | $0 | 2024–2024 | 1.9x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2018 | 4 | $866K | $1.8M | $3.5M |
| 2019 | 5 | $768K | $1.9M | $3.8M |
| 2020 | 6 | $1.2M | $3.3M | $7.1M |
| 2021 | 13 | $932K | $3.7M | $12.1M |
| 2024 | 21 | $1.0M | $5.4M | $20.7M |
Email Alerts
Get notified about BETH ISRAEL LAHEY HEALTH PHARMACY INC
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.